MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Treatment"

  • 2023 International Congress

    Outcomes of Focused Ultrasound Thalamotomy in Tremor Syndromes

    J. Peters, J. Maamary, K. Kyle, N. Olsen, L. Jones, S. Bolitho, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

    Objective: To report on the outcomes between tremor subtypes, Essential Tremor (ET), Dystonic Tremor (DT) and Parkinson Disease Tremor (PDT), following a unilateral Magnetic Resonance…
  • 2023 International Congress

    The added value of accelerometric monitoring during thalamotomy

    A. Smid, M. Oterdoom, R. Pauwels, K. Tamasi, J. Elting, A. Absalom, T. van Laar, M. van Dijk, G. Drost (Groningen, Netherlands)

    Objective: To quantify the clinical changes in tremor during the different stages of thalamotomy, and to investigate the relationship between intraoperative findings and clinical outcome.…
  • 2023 International Congress

    The feasibility of MRI guided focused ultrasound for posttraumatic tremor with prior hemicraniotomy and skull defect

    J. Maamary, J. Peters, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

    Objective: To assess the feasibility of MRgFUS lesioning in the context of prior hemicraniotomy Background: Targeted stereotactic lesioning, using MRgFUS, is an effective treatment option…
  • 2023 International Congress

    Improved Tremor Response to Focused Ultrasound Thalamotomy

    J. Holcomb, R. Chopra, F. Feltrin, M. Elkurd, R. El-Nazer, L. Mckenzie, P. O’Suillebhain, J. Maldjian, W. Dauer, B. Shah (Dallas, USA)

    Objective: This study sought to determine if, when using four tract tractography (FTT) to target the decussating and non-decussating dentatorubrothalamic tracts (DRTTs), essential tremor (ET)…
  • 2023 International Congress

    Anti-tremor efficacy of Nabiximols (JZP378) in a rat Model of essential tremor

    S. Loomis, E. Samoylenko, D. Virley, A. Mccreary (Cambridge, United Kingdom)

    Objective: To assess the effect of acute and subchronic oral administration of nabiximols (JZP378), a complex botanical cannabinoid drug mixture with Δ9-tetrahydrocannabinol (THC) and cannabidiol…
  • 2023 International Congress

    Isolated vocal tremor: a case series

    J. Bundy, Y. Kianirad (Chicago, USA)

    Objective: To describe the difficulties and limited treatment options for isolated vocal tremor. Background: Isolated vocal tremor is a unique phenotype of isolated focal tremor…
  • 2023 International Congress

    Instability after MRIg-FUS thalamotomy: why does it appear?

    A. Fernandez Revuelta, C. Ribacoba Díaz, J. Porta Etessam, C. Pérez García, M. Yus, E. López Valdés, R. García-Ramos (Madrid, Spain)

    Objective: To know the semiological characteristics and physiopathology of instability after thalamotomy with Magnetic Resonance image guided focused ultrasound thalamotomy (MRIg-FUS). Background: Gait instability is…
  • 2023 International Congress

    KINETIC 2: An ongoing phase 2b, randomized, dose-response study of SAGE-324/BIIB124 for the treatment of essential tremor

    R. Pahwa, A. Ellenbogen, D. Arkilo, T. Dam, T. Lieu, B. Hersh, M. Qin, S. Garafola, M. Gerbasi, H. Colquhoun (Kansas City, KS, USA)

    Objective: KINETIC 2 (NCT05173012) is an ongoing, phase 2b, randomized, double-blind, placebo-controlled, dose-response study that aims to evaluate the efficacy, safety, and tolerability of SAGE-324/BIIB124…
  • 2023 International Congress

    Design of a Phase 2 Study of Suvecaltamide in Moderate to Severe Parkinson’s Disease Tremor

    R. Hauser, C. Adler, G. Deuschl, M. Baladi, P. Chandler, T. Skarpass, K. Xu, P. Lewitt (Tampa, USA)

    Objective: Describe the design of a phase 2 study (NCT05642442) of a once-daily, extended-release formulation of suvecaltamide to treat moderate to severe Parkinson’s disease tremor…
  • 2023 International Congress

    Patient experiences in essential tremor: mapping functional impacts to existing measures using qualitative research

    M. Gerbasi, D. Goss, J. Petrillo, M. Nejati, S. Lewis (Cambridge, USA)

    Objective: To understand patient experience in essential tremor (ET), describe meaningful concepts related to treatment benefit, and compare concepts to existing clinical outcome assessments (COAs).…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley